Beginning Cash: The amount of cash reported by the company on its previous statement.
INmune Bio, Inc. (INMB) had Beginning Cash of $35.85M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-12.09M |
|
-- |
|
-- |
|
$12.29M |
|
$-12.29M |
|
$0.19M |
|
$-12.09M |
|
$-12.09M |
|
$-12.09M |
|
$-12.09M |
|
$-12.09M |
|
$-12.09M |
|
$-12.29M |
|
$-12.27M |
|
20.19M |
|
20.19M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$35.85M |
|
-- |
|
$16.93M |
|
$52.78M |
|
$13.82M |
|
-- |
|
$0.28M |
|
$14.11M |
|
$38.67M |
|
$22.16M |
|
$38.67M |
|
22.17M |
|
| Cash Flow Statement Financials | |
$-22.35M |
|
-- |
|
$20.29M |
|
|
Beginning Cash |
$35.85M |
$33.55M |
|
$-2.30M |
|
$5.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.59 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.27% |
|
-54.57% |
|
-22.91% |
|
-31.27% |
|
$1.74 |
|
$-1.11 |
|
$-1.11 |
|